Disease Information
General Information of the Disease (ID: DIS00012)
Name |
Salmonellosis
|
---|---|
ICD |
ICD-11: 1A09
|
Resistance Map |
Type(s) of Resistant Mechanism of This Disease
ADTT: Aberration of the Drug's Therapeutic Target
DISM: Drug Inactivation by Structure Modification
IDUE: Irregularity in Drug Uptake and Drug Efflux
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
18 drug(s) in total
Acriflavine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug resistance protein MdtK (MDTK) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Acriflavine | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtk confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Acriflavine | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Acriflavine | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Acriflavine | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Ceftazidime
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Key Molecule: Beta-lactamase (BLA) | [2] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Ceftazidime | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Enterobacter cloacae strains ENLA-1 | 550 | ||
Escherichia coli strain ECAA-1 | 562 | |||
Escherichia coli strain ECLA-1 | 562 | |||
Escherichia coli strain ECLA-2 | 562 | |||
Escherichia coli strain ECLA-4 | 562 | |||
Escherichia coli strain ECZK-1 | 562 | |||
Escherichia coli strain ECZP-1 | 562 | |||
Escherichia coli strain ECZU-1 | 562 | |||
Escherichia coli strain HK225f | 562 | |||
Salmonella enterica serotype wien strain SWLA-1 | 149384 | |||
Salmonella enterica serotype wien strain SWLA-2 | 149384 | |||
Klebsiella pneumoniae strains kPAA-1 | 573 | |||
Klebsiella pneumoniae strains kPBE-2 | 573 | |||
Klebsiella pneumoniae strains kPGE-1 | 573 | |||
Klebsiella pneumoniae strains kPGE-2 | 573 | |||
Klebsiella pneumoniae strains kPLA-1 | 573 | |||
Klebsiella pneumoniae strains kPLA-10 | 573 | |||
Klebsiella pneumoniae strains kPLA-2 | 573 | |||
Klebsiella pneumoniae strains kPLA-3 | 573 | |||
Klebsiella pneumoniae strains kPLA-4 | 573 | |||
Klebsiella pneumoniae strains kPLA-5 | 573 | |||
Klebsiella pneumoniae strains kPLA-6 | 573 | |||
Klebsiella pneumoniae strains kPLA-7 | 573 | |||
Klebsiella pneumoniae strains kPLA-8 | 573 | |||
Klebsiella pneumoniae strains kPLA-9 | 573 | |||
Klebsiella pneumoniae strains kPZU-1 | 573 | |||
Klebsiella pneumoniae strains kPZU-10 | 573 | |||
Klebsiella pneumoniae strains kPZU-11 | 573 | |||
Klebsiella pneumoniae strains kPZU-12 | 573 | |||
Klebsiella pneumoniae strains kPZU-13 | 573 | |||
Klebsiella pneumoniae strains kPZU-4 | 573 | |||
Klebsiella pneumoniae strains kPZU-6 | 573 | |||
Klebsiella pneumoniae strains kPZU-7 | 573 | |||
Klebsiella pneumoniae strains kPZU-8 | 573 | |||
Klebsiella pneumoniae strains kPZU-9 | 573 | |||
Experiment for Molecule Alteration |
Hybridization experiments assay | |||
Experiment for Drug Resistance |
Microdilution method assay | |||
Mechanism Description | Of 60 strains with reduced susceptibility to expanded-spectrum cephalosporins which had been collected, 34 (24Klebsiella pneumoniae, 7Escherichia coli, 1Enterobacter cloacae, and 2Salmonella entericaserotypewien) hybridized with the intragenic blaSHVprobe. TheblaSHVgenes were amplified by PCR, and the presence ofblaSHV-ESBLwas established in 29 strains by restriction enzyme digests of the resulting 1,018-bp amplimers as described elsewhere. These results were confirmed by the nucleotide sequencing of all 34 amplimers. Five strains contained SHV non-ESBL enzymes. |
Ceftriaxone
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Key Molecule: Beta-lactamase (BLA) | [2] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Ceftriaxone | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Enterobacter cloacae strains ENLA-1 | 550 | ||
Escherichia coli strain ECAA-1 | 562 | |||
Escherichia coli strain ECLA-1 | 562 | |||
Escherichia coli strain ECLA-2 | 562 | |||
Escherichia coli strain ECLA-4 | 562 | |||
Escherichia coli strain ECZK-1 | 562 | |||
Escherichia coli strain ECZP-1 | 562 | |||
Escherichia coli strain ECZU-1 | 562 | |||
Escherichia coli strain HK225f | 562 | |||
Salmonella enterica serotype wien strain SWLA-1 | 149384 | |||
Salmonella enterica serotype wien strain SWLA-2 | 149384 | |||
Klebsiella pneumoniae strains kPAA-1 | 573 | |||
Klebsiella pneumoniae strains kPBE-2 | 573 | |||
Klebsiella pneumoniae strains kPGE-1 | 573 | |||
Klebsiella pneumoniae strains kPGE-2 | 573 | |||
Klebsiella pneumoniae strains kPLA-1 | 573 | |||
Klebsiella pneumoniae strains kPLA-10 | 573 | |||
Klebsiella pneumoniae strains kPLA-2 | 573 | |||
Klebsiella pneumoniae strains kPLA-3 | 573 | |||
Klebsiella pneumoniae strains kPLA-4 | 573 | |||
Klebsiella pneumoniae strains kPLA-5 | 573 | |||
Klebsiella pneumoniae strains kPLA-6 | 573 | |||
Klebsiella pneumoniae strains kPLA-7 | 573 | |||
Klebsiella pneumoniae strains kPLA-8 | 573 | |||
Klebsiella pneumoniae strains kPLA-9 | 573 | |||
Klebsiella pneumoniae strains kPZU-1 | 573 | |||
Klebsiella pneumoniae strains kPZU-10 | 573 | |||
Klebsiella pneumoniae strains kPZU-11 | 573 | |||
Klebsiella pneumoniae strains kPZU-12 | 573 | |||
Klebsiella pneumoniae strains kPZU-13 | 573 | |||
Klebsiella pneumoniae strains kPZU-4 | 573 | |||
Klebsiella pneumoniae strains kPZU-6 | 573 | |||
Klebsiella pneumoniae strains kPZU-7 | 573 | |||
Klebsiella pneumoniae strains kPZU-8 | 573 | |||
Klebsiella pneumoniae strains kPZU-9 | 573 | |||
Experiment for Molecule Alteration |
Hybridization experiments assay | |||
Experiment for Drug Resistance |
Microdilution method assay | |||
Mechanism Description | Of 60 strains with reduced susceptibility to expanded-spectrum cephalosporins which had been collected, 34 (24Klebsiella pneumoniae, 7Escherichia coli, 1Enterobacter cloacae, and 2Salmonella entericaserotypewien) hybridized with the intragenic blaSHVprobe. TheblaSHVgenes were amplified by PCR, and the presence ofblaSHV-ESBLwas established in 29 strains by restriction enzyme digests of the resulting 1,018-bp amplimers as described elsewhere. These results were confirmed by the nucleotide sequencing of all 34 amplimers. Five strains contained SHV non-ESBL enzymes. |
Chloramphenicol
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug transporter MdfA (MDFA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Chloramphenicol | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdfA confers drug resistance. | |||
Key Molecule: Catalase isozyme A/Tetracycline efflux MFS transporter/Dihydropteroate synthase (CATA1/TETB/SUL) | [3] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Chloramphenicol | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella agona 231 | 58095 | ||
Experiment for Molecule Alteration |
PCR screening assay | |||
Experiment for Drug Resistance |
Disc diffusion assay | |||
Mechanism Description | The multiresistance plasmid from S. Agona strain 231 carried the chloramphenicol resistance gene catA1 coding for a type A chloramphenicol acetyltransferase and the resistance gene tet(B) coding for a tetracycline/minocycline exporter. This plasmid also harboured the streptomycin resistance gene strA coding for an aminoglycoside phosphotransferase and the sulphonamide resistance gene sul1 which represents part of the 3' conserved segment of class 1 integrons. | |||
Key Molecule: Bcr/CflA family efflux transporter (BCML) | [4] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Chloramphenicol | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serotype Typhimurium SS034 | 90371 | ||
Salmonella enterica serotype Typhimurium 1358 | 90371 | |||
Salmonella enterica serotype Typhimurium 2039 | 90371 | |||
Salmonella enterica serotype Typhimurium 2152 | 90371 | |||
Salmonella enterica serotype Typhimurium 2668 | 90371 | |||
Salmonella enterica serotype Typhimurium 2855 | 90371 | |||
Salmonella enterica serotype Typhimurium 3430 | 90371 | |||
Salmonella enterica serotype Typhimurium 3977 | 90371 | |||
Salmonella enterica serotype Typhimurium 4204 | 90371 | |||
Salmonella enterica serotype Typhimurium 4255 | 90371 | |||
Salmonella enterica serotype Typhimurium 4287 | 90371 | |||
Salmonella enterica serotype Typhimurium 4501 | 90371 | |||
Salmonella enterica serotype Typhimurium 4528 | 90371 | |||
Salmonella enterica serotype Typhimurium 4656 | 90371 | |||
Salmonella enterica serotype Typhimurium 922 | 90371 | |||
Experiment for Molecule Alteration |
Southern blot hybridizations assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Isolates 2039 and 2152 also carried an additional integron (In-t4) that encodes the cmlA and aadB gene cassettes, which confer resistance to chloramphenicol and kanamycin, respectively. |
Colistin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Key Molecule: Hydrolase (HYDE) | [5] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Colistin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli NEB5alpha | 562 | ||
Experiment for Molecule Alteration |
In silico EMBOSS Transeq assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | Mcr-1 is a phosphoethanolamine transferase that modifies cell membrane lipid A head groups with a phosphoethanolamine residue, reducing affinity to colistin. |
Doxorubicin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug transporter MdfA (MDFA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Doxorubicin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdfA confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtK (MDTK) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Doxorubicin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtk confers drug resistance. |
Erythromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Macrolide export ATP-binding/permease protein MacB (MACB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Erythromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of macAB confers drug resistance. |
Gentian violet
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Gentian violet | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Gentian violet | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Gentian violet | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Methylene blue
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Methylene blue | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Methylene blue | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Methylene blue | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Nalidixic acid
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug export protein EmrA (EMRA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Nalidixic acid | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. | |||
Key Molecule: Multidrug export protein EmrB (EMRB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Nalidixic acid | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. |
Norfloxacin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug transporter MdfA (MDFA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Norfloxacin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdfA confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtK (MDTK) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Norfloxacin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtk confers drug resistance. |
Novobiocin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug resistance protein MdtC (MDTC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtB (MDTB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtA (MDTA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter (ACRD) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of acrD confers drug resistance. | |||
Key Molecule: Multidrug export protein EmrA (EMRA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. | |||
Key Molecule: Multidrug export protein EmrB (EMRB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Novobiocin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Reserpine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: MAPK/ERK kinase 1 (MEK1) | [6] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Function | Activation |
||
Resistant Drug | Reserpine | |||
Experimental Note | Discovered Using In-vivo Testing Model | |||
Cell Pathway Regulation | T cell receptor signaling pathway | Regulation | hsa04660 | |
EGFR signaling pathway | Inhibition | hsa01521 | ||
mTOR signaling pathway | Inhibition | hsa04150 | ||
MEK1/2 signaling pathway | Activation | hsa04010 | ||
In Vivo Model | Chicken ceca explant model | Gallus gallus | ||
Experiment for Molecule Alteration |
Chicken-specific kinome peptide array | |||
Experiment for Drug Resistance |
Bactericidal assays against Salmonella | |||
Mechanism Description | Reserpine treatment induced T cell activation, reduced CTLA-4 gene expression, and deactivated metabolic pathways like epidermal growth factor receptor (EGFR) signaling and mammalian target of rapamycin (mTOR) signaling, which were linked to antimicrobial responses. MEK1/2 activation plays a central role in reserpine-induced antimicrobial activities. |
Sodium lauryl sulfate
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug resistance protein MdtC (MDTC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium lauryl sulfate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtB (MDTB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium lauryl sulfate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtA (MDTA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium lauryl sulfate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter (ACRD) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium lauryl sulfate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of acrD confers drug resistance. |
Spectinomycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Key Molecule: Aminoglycoside (3'') (9) adenylyltransferase (AADA) | [7] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Spectinomycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar typhimurium strain | 90371 | ||
Experiment for Molecule Alteration |
PCR | |||
Experiment for Drug Resistance |
Disk diffusion method assay | |||
Mechanism Description | Besides the genes present in the multidrug-resistant Salmonella serovar Typhimurium strains, other genes related to antibiotic resistance were described in Salmonella serovar Typhimurium or other closely related species. Tetracycline resistance could also be encoded by tetA, tetB, tetC or aadA21. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Catalase isozyme A/Tetracycline efflux MFS transporter/Dihydropteroate synthase (CATA1/TETB/SUL) | [3] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Spectinomycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella agona 231 | 58095 | ||
Experiment for Molecule Alteration |
PCR screening assay | |||
Experiment for Drug Resistance |
Disc diffusion assay | |||
Mechanism Description | The multiresistance plasmid from S. Agona strain 231 carried the chloramphenicol resistance gene catA1 coding for a type A chloramphenicol acetyltransferase and the resistance gene tet(B) coding for a tetracycline/minocycline exporter. This plasmid also harboured the streptomycin resistance gene strA coding for an aminoglycoside phosphotransferase and the sulphonamide resistance gene sul1 which represents part of the 3' conserved segment of class 1 integrons. |
Streptomycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Key Molecule: Aminoglycoside (3'') (9) adenylyltransferase (AADA) | [7] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Streptomycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar typhimurium strain | 90371 | ||
Experiment for Molecule Alteration |
PCR | |||
Experiment for Drug Resistance |
Disk diffusion method assay | |||
Mechanism Description | Besides the genes present in the multidrug-resistant Salmonella serovar Typhimurium strains, other genes related to antibiotic resistance were described in Salmonella serovar Typhimurium or other closely related species. Tetracycline resistance could also be encoded by tetA, tetB, tetC or aadA21. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Catalase isozyme A/Tetracycline efflux MFS transporter/Dihydropteroate synthase (CATA1/TETB/SUL) | [3] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Streptomycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella agona 231 | 58095 | ||
Experiment for Molecule Alteration |
PCR screening assay | |||
Experiment for Drug Resistance |
Disc diffusion assay | |||
Mechanism Description | The multiresistance plasmid from S. Agona strain 231 carried the chloramphenicol resistance gene catA1 coding for a type A chloramphenicol acetyltransferase and the resistance gene tet(B) coding for a tetracycline/minocycline exporter. This plasmid also harboured the streptomycin resistance gene strA coding for an aminoglycoside phosphotransferase and the sulphonamide resistance gene sul1 which represents part of the 3' conserved segment of class 1 integrons. |
Tetracycline
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug transporter MdfA (MDFA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Tetracycline | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdfA confers drug resistance. |
Trimethoprim
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Catalase isozyme A/Tetracycline efflux MFS transporter/Dihydropteroate synthase (CATA1/TETB/SUL) | [3] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Trimethoprim | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella agona 231 | 58095 | ||
Experiment for Molecule Alteration |
PCR screening assay | |||
Experiment for Drug Resistance |
Disc diffusion assay | |||
Mechanism Description | The multiresistance plasmid from S. Agona strain 231 carried the chloramphenicol resistance gene catA1 coding for a type A chloramphenicol acetyltransferase and the resistance gene tet(B) coding for a tetracycline/minocycline exporter. This plasmid also harboured the streptomycin resistance gene strA coding for an aminoglycoside phosphotransferase and the sulphonamide resistance gene sul1 which represents part of the 3' conserved segment of class 1 integrons. |
Clinical Trial Drug(s)
1 drug(s) in total
Rhodamine 6G
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug export protein EmrA (EMRA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Rhodamine 6G | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. | |||
Key Molecule: Multidrug export protein EmrB (EMRB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Rhodamine 6G | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Rhodamine 6G | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Rhodamine 6G | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Rhodamine 6G | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Investigative Drug(s)
7 drug(s) in total
Benzalkonium bromide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Benzalkonium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Benzalkonium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Benzalkonium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Homidium bromide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Homidium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Homidium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Homidium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Microcin J25
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: ABC transporter ATP-binding/permease protein YojI (YOJI) | [8] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Microcin J25 | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli k-12 | 83333 | ||
Experiment for Molecule Alteration |
Promega and one-step chromosomal gene inactivation method assay | |||
Experiment for Drug Resistance |
Spot-on-lawn assay | |||
Mechanism Description | YojI, an Escherichia coli open reading frame with an unknown function, mediates resistance to the peptide antibiotic microcin J25 when it is expressed from a multicopy vector. Disruption of the single chromosomal copy of yojI increased sensitivity of cells to microcin J25. One obvious explanation for the protective effect against microcin J25 is that YojI action keeps the intracellular concentration of the peptide below a toxic level. the resistance to MccJ25 mediated by YojI involves extrusion of the peptide and that YojI is assisted by the multifunctional outer membrane protein TolC. |
Sodium deoxycholate
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Multidrug resistance protein MdtC (MDTC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtB (MDTB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Multidrug resistance protein MdtA (MDTA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of mdtABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter (ACRD) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of acrD confers drug resistance. | |||
Key Molecule: Multidrug export protein EmrA (EMRA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. | |||
Key Molecule: Multidrug export protein EmrB (EMRB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of emrAB confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Sodium deoxycholate | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
Sulphonamides
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Catalase isozyme A/Tetracycline efflux MFS transporter/Dihydropteroate synthase (CATA1/TETB/SUL) | [3] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Sulphonamides | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella agona 231 | 58095 | ||
Experiment for Molecule Alteration |
PCR screening assay | |||
Experiment for Drug Resistance |
Disc diffusion assay | |||
Mechanism Description | The multiresistance plasmid from S. Agona strain 231 carried the chloramphenicol resistance gene catA1 coding for a type A chloramphenicol acetyltransferase and the resistance gene tet(B) coding for a tetracycline/minocycline exporter. This plasmid also harboured the streptomycin resistance gene strA coding for an aminoglycoside phosphotransferase and the sulphonamide resistance gene sul1 which represents part of the 3' conserved segment of class 1 integrons. |
Tetracycline/Minocycline
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Catalase isozyme A/Tetracycline efflux MFS transporter/Dihydropteroate synthase (CATA1/TETB/SUL) | [3] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Tetracycline/Minocycline | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella agona 231 | 58095 | ||
Experiment for Molecule Alteration |
PCR screening assay | |||
Experiment for Drug Resistance |
Disc diffusion assay | |||
Mechanism Description | The multiresistance plasmid from S. Agona strain 231 carried the chloramphenicol resistance gene catA1 coding for a type A chloramphenicol acetyltransferase and the resistance gene tet(B) coding for a tetracycline/minocycline exporter. This plasmid also harboured the streptomycin resistance gene strA coding for an aminoglycoside phosphotransferase and the sulphonamide resistance gene sul1 which represents part of the 3' conserved segment of class 1 integrons. |
Tetraphenylphosphonium bromide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Tetraphenylphosphonium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Tetraphenylphosphonium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Tetraphenylphosphonium bromide | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.